Merck ends development of Covid drug it acquired from OncoImmune

Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.

from Health and Science https://ift.tt/3srjHlK
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH